Matching slides 60,568
Current window 33,961-33,990
Pages 2,019
Rows per page 30
Component: Tableclear collectionreset all

Component

33,961-33,990 of 60,568

filter-aware
25
Includes bar charts for degradation and physiological markers, plus a line chart for EAE clinical scores.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
27
SAD = Single Ascending Dose; MAD = Multiple Ascending Dose.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
28
The chart displays mean (± SE) percent IRAK4 change from baseline. P-values are relative to placebo.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
31
The table uses checkmarks to indicate inhibition activity across different targets and stimuli.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
32
SAD = Single Ascending Dose; AE = Adverse Event; SAE = Serious Adverse Event.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
33
The slide compares Day 1 and Day 14 PK profiles, highlighting the accumulation and steady-state achievement.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
35
Data shows high efficacy at lower doses with a plateau effect observed at 100mg.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
37
Data shows significantly higher accumulation in skin tissue compared to plasma at trough levels.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
41
The table details specific adverse events (Headache, Palpitations, Nausea) with subject counts, severity, and cohort distribution.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
46
The slide uses a grid layout to map drug assets against therapeutic areas (Dermatology, Respiratory, GI, Rheumatology, Hematology, Neurology, Oncology) and color-coded mechanisms of action.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
51
The slide uses a structured layout to contrast patient numbers with clinical disease characteristics.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
53
Includes tumor volume growth curves and PK/PD degradation profiles.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
69
The slide uses a structured table-like layout to map diseases to patient impact metrics and scientific evidence.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
70
The slide displays bar charts for fibrosis and bone growth, and line charts for clinical scores in arthritis and EAE models, alongside a summary table for the EAE model.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
74
The slide uses a timeline-based grid to map specific assets (KT-474, KT-413, KT-253, KT-333) and future target pipelines against years 2021-2026.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
78
The slide uses a three-part process flow (degradation -> stabilization -> killing) supported by dose-response curves and a summary table.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
86
The slide uses a visual metaphor of a 'wedge' expanding the druggable portion of the human proteome.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
93
The slide uses a process flow diagram for the fragment-based optimization and a heatmap for the covalent ligand screening.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
94
The table demonstrates a clear progression in optimization from Degrader 1 to Degrader 4, particularly in oral bioavailability (F%) across species.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
100
The slide uses a color-coded system to distinguish between Oncology (dark blue) and Immunology-Inflammation (orange) programs.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
09
The slide uses a timeline-like structure to present key deal terms and financial highlights.Nauticus | SPAC Presentation Deck | 41 slides · Nauticus Robotics
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
25
Includes a map visualization of global wind farm activity and a bar chart of European turbine counts by country.Nauticus | SPAC Presentation Deck | 41 slides · Nauticus Robotics
Pitch deck Investment bank Beat · Market Sizing1 hit
39
The table includes valuation multiples (EV/EBITDA, EV/Revenue) and performance metrics (Revenue Growth, EBITDA margin) across multiple years.Nauticus | SPAC Presentation Deck | 41 slides · Nauticus Robotics
Pitch deck Investment bank 1 hit
13
The slide uses a 'Charts', 'Huddle', 'Tasking' vertical label structure on the left to categorize the screenshots.Oak Street Health | Investor Presentation Deck | 27 slides · Oak Street Health
Pitch deck Investor relations 1 hit
16
The slide uses a combination of visual mapping, historical data tables, and social proof (logos) to validate scalability.Oak Street Health | Investor Presentation Deck | 27 slides · Oak Street Health
Pitch deck Investor relations 1 hit
26
The table presents financial guidance in millions of dollars.Oak Street Health | Investor Presentation Deck | 27 slides · Oak Street Health
Pitch deck Investor relations 1 hit
07
The slide presents financial guidance updates for FY2022.Skillsoft | Investor Presentation Deck | 39 slides · Skillsoft
Pitch deck Investor relations 1 hit
11
The slide uses a matrix structure to define market segments, value propositions, and competitive positioning.Skillsoft | Investor Presentation Deck | 39 slides · Skillsoft
Pitch deck Investor relations Beat · Solution1 hit
17
Uses a Venn diagram to show internal strengths and a matrix to show strategic fit of acquisitions.Skillsoft | Investor Presentation Deck | 39 slides · Skillsoft
Pitch deck Investor relations 1 hit
20
The slide highlights the transition of the customer base to the Percipio platform and its positive impact on retention and new business.Skillsoft | Investor Presentation Deck | 39 slides · Skillsoft
Pitch deck Investor relations Loop · Cost Of Inaction1 hit